vs
ANGIODYNAMICS INC（ANGO）与万物新生（RERE）财务数据对比。点击上方公司名可切换其他公司
ANGIODYNAMICS INC的季度营收约是万物新生的1.8倍（$79.4M vs $43.2M），万物新生净利率更高（16.9% vs -8.0%，领先24.9%）
AngioDynamics是一家全球医疗技术企业，专注于研发、生产及销售微创医疗设备，核心产品覆盖血管通路、外科消融、肿瘤治疗等领域，面向北美、欧洲、亚太地区的医院、门诊手术中心及各类医疗机构提供服务。
万物新生集团（ATRenew Inc.）是中国领先的二手消费电子产品交易与服务平台运营商，核心业务覆盖数码产品回收、质检、翻新及售卖，运营有爱回收等知名品牌，服务覆盖个人消费者及企业客户，市场遍及国内及部分东南亚地区。
ANGO vs RERE — 直观对比
营收规模更大
ANGO
是对方的1.8倍
$43.2M
净利率更高
RERE
高出24.9%
-8.0%
损益表 — Q2 FY2026 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $43.2M |
| 净利润 | $-6.3M | $7.3M |
| 毛利率 | 56.4% | — |
| 营业利润率 | -7.7% | — |
| 净利率 | -8.0% | 16.9% |
| 营收同比 | 9.0% | — |
| 净利润同比 | 40.9% | — |
| 每股收益（稀释后） | $-0.15 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANGORERE
| Q4 25 | $79.4M | — | ||
| Q3 25 | $75.7M | — | ||
| Q2 25 | $80.2M | — | ||
| Q1 25 | $72.0M | — | ||
| Q4 24 | $72.8M | — | ||
| Q3 24 | $67.5M | — | ||
| Q2 24 | $71.0M | — | ||
| Q1 24 | $75.2M | — |
净利润ANGORERE
| Q4 25 | $-6.3M | — | ||
| Q3 25 | $-10.9M | — | ||
| Q2 25 | $-6.0M | — | ||
| Q1 25 | $-4.4M | — | ||
| Q4 24 | $-10.7M | — | ||
| Q3 24 | $-12.8M | — | ||
| Q2 24 | $-13.4M | — | ||
| Q1 24 | $-187.7M | — |
毛利率ANGORERE
| Q4 25 | 56.4% | — | ||
| Q3 25 | 55.3% | — | ||
| Q2 25 | 52.7% | — | ||
| Q1 25 | 54.0% | — | ||
| Q4 24 | 54.8% | — | ||
| Q3 24 | 54.4% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 47.7% | — |
营业利润率ANGORERE
| Q4 25 | -7.7% | — | ||
| Q3 25 | -14.1% | — | ||
| Q2 25 | -7.2% | — | ||
| Q1 25 | -13.9% | — | ||
| Q4 24 | -15.2% | — | ||
| Q3 24 | -19.4% | — | ||
| Q2 24 | -20.4% | — | ||
| Q1 24 | -265.9% | — |
净利率ANGORERE
| Q4 25 | -8.0% | — | ||
| Q3 25 | -14.4% | — | ||
| Q2 25 | -7.5% | — | ||
| Q1 25 | -6.1% | — | ||
| Q4 24 | -14.7% | — | ||
| Q3 24 | -19.0% | — | ||
| Q2 24 | -18.9% | — | ||
| Q1 24 | -249.7% | — |
每股收益（稀释后）ANGORERE
| Q4 25 | $-0.15 | — | ||
| Q3 25 | $-0.26 | — | ||
| Q2 25 | $-0.15 | — | ||
| Q1 25 | $-0.11 | — | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.35 | — | ||
| Q1 24 | $-4.67 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.6M | $228.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $176.3M | $557.1M |
| 总资产 | $269.7M | $722.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ANGORERE
| Q4 25 | $41.6M | — | ||
| Q3 25 | $38.8M | — | ||
| Q2 25 | $55.9M | — | ||
| Q1 25 | $44.8M | — | ||
| Q4 24 | $54.1M | — | ||
| Q3 24 | $55.0M | — | ||
| Q2 24 | $76.1M | — | ||
| Q1 24 | $78.5M | — |
总债务ANGORERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | — | — |
股东权益ANGORERE
| Q4 25 | $176.3M | — | ||
| Q3 25 | $178.9M | — | ||
| Q2 25 | $183.0M | — | ||
| Q1 25 | $185.9M | — | ||
| Q4 24 | $186.8M | — | ||
| Q3 24 | $196.6M | — | ||
| Q2 24 | $205.6M | — | ||
| Q1 24 | $218.7M | — |
总资产ANGORERE
| Q4 25 | $269.7M | — | ||
| Q3 25 | $265.6M | — | ||
| Q2 25 | $280.1M | — | ||
| Q1 25 | $285.4M | — | ||
| Q4 24 | $291.6M | — | ||
| Q3 24 | $293.6M | — | ||
| Q2 24 | $317.7M | — | ||
| Q1 24 | $324.8M | — |
负债/权益比ANGORERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.7M | — |
| 自由现金流经营现金流 - 资本支出 | $4.2M | — |
| 自由现金流率自由现金流/营收 | 5.3% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.3M | — |
8季度趋势，按日历期对齐
经营现金流ANGORERE
| Q4 25 | $4.7M | — | ||
| Q3 25 | $-15.9M | — | ||
| Q2 25 | $18.8M | — | ||
| Q1 25 | $-13.2M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $-18.3M | — | ||
| Q2 24 | $5.0M | — | ||
| Q1 24 | $-12.5M | — |
自由现金流ANGORERE
| Q4 25 | $4.2M | — | ||
| Q3 25 | $-16.6M | — | ||
| Q2 25 | $18.0M | — | ||
| Q1 25 | $-15.0M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $-19.3M | — | ||
| Q2 24 | $4.4M | — | ||
| Q1 24 | $-13.1M | — |
自由现金流率ANGORERE
| Q4 25 | 5.3% | — | ||
| Q3 25 | -22.0% | — | ||
| Q2 25 | 22.5% | — | ||
| Q1 25 | -20.8% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | -28.7% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | -17.5% | — |
资本支出强度ANGORERE
| Q4 25 | 0.5% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.8% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANGO
| Med Device | $37.2M | 47% |
| Med Tech | $30.4M | 38% |
| Other | $11.8M | 15% |
RERE
暂无分部数据
